107 related articles for article (PubMed ID: 1279507)
21. A pituitary carcinoma secreting TSH and prolactin: a non-secreting adenoma gone awry.
Brown RL; Muzzafar T; Wollman R; Weiss RE
Eur J Endocrinol; 2006 May; 154(5):639-43. PubMed ID: 16645009
[TBL] [Abstract][Full Text] [Related]
22. Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation.
Atkin SL; Landolt AM; Jeffreys RV; Diver M; Radcliffe J; White MC
J Clin Endocrinol Metab; 1993 Sep; 77(3):831-7. PubMed ID: 8370706
[TBL] [Abstract][Full Text] [Related]
23. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
Kristof RA; Schramm J; Redel L; Neuloh G; Wichers M; Klingmüller D
Acta Neurochir (Wien); 2002 Jun; 144(6):555-61; discussion 561. PubMed ID: 12111488
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of hormone secretion in GH-secreting pituitary adenomas by receptor-subtype specific somatostatin analogues in vitro.
Cap J; Marekova M; Cerman J; Malirova E; Suba P; Netuka D; Hana V; Marek J
Gen Physiol Biophys; 2003 Jun; 22(2):201-12. PubMed ID: 14661732
[TBL] [Abstract][Full Text] [Related]
25. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW
J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
[TBL] [Abstract][Full Text] [Related]
26. Moyamoya disease associated with pituitary adenoma--report of two cases.
Arita K; Uozumi T; Oki S; Kuwabara S; Ohba S; Nakahara T; Muttaqin Z; Kohno H; Yamada K
Neurol Med Chir (Tokyo); 1992 Sep; 32(10):753-7. PubMed ID: 1280777
[TBL] [Abstract][Full Text] [Related]
27. Pituitary adenomas in acromegalic patients: an immunohistochemical and endocrinological study with special reference to prolactin-secreting adenoma.
Kanie N; Kageyama N; Kuwayama A; Nakane T; Watanabe M; Kawaoi A
J Clin Endocrinol Metab; 1983 Dec; 57(6):1093-101. PubMed ID: 6415083
[TBL] [Abstract][Full Text] [Related]
28. [Functional morphology of pituitary adenoma in acromegaly].
Kasumova SIu; Barabonov VM; Snigireva RIa
Arkh Patol; 1982; 44(5):19-25. PubMed ID: 6287977
[TBL] [Abstract][Full Text] [Related]
29. A new look at pituitary adenomas: structure elucidating function.
Sirek AM; Corenblum B; Horvath E; Rewcastle B; Ezrin C; Kovacs K
Can Med Assoc J; 1976 Feb; 114(3):225-9. PubMed ID: 204403
[TBL] [Abstract][Full Text] [Related]
30. [Calcified prolactinomas].
Guerrero E; Pallardo LF; Santiago M; Pérez Alvarez M; López J; Fernández D; Cerdán A
Rev Clin Esp; 1983 Sep; 170(6):299-301. PubMed ID: 6318278
[No Abstract] [Full Text] [Related]
31. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
[TBL] [Abstract][Full Text] [Related]
32. [Pituitary adenomas extending into the orbit].
Akshulakov SK; Serova NK
Zh Vopr Neirokhir Im N N Burdenko; 1986; (4):36-9. PubMed ID: 3766007
[TBL] [Abstract][Full Text] [Related]
33. Amyloid formation in prolactinoma.
Kubota T; Kuroda E; Yamashima T; Tachibana O; Kabuto M; Yamamoto S
Arch Pathol Lab Med; 1986 Jan; 110(1):72-5. PubMed ID: 3510059
[TBL] [Abstract][Full Text] [Related]
34. Amorphous and stellate amyloid in functioning human pituitary adenomas: histochemical, immunohistochemical and electron microscopic studies.
Osamura RY; Watanabe K; Komatsu N; Ohya M; Kageyama N
Acta Pathol Jpn; 1982 Jul; 32(4):605-11. PubMed ID: 7113700
[TBL] [Abstract][Full Text] [Related]
35. Macroprolactinaemia associated with prolactin adenoma.
Mounier C; Trouillas J; Claustrat B; Duthel R; Estour B
Hum Reprod; 2003 Apr; 18(4):853-7. PubMed ID: 12660284
[TBL] [Abstract][Full Text] [Related]
36. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
37. Acromegaly and thyrotoxicosis induced by a GH- and TSH-producing pituitary tumour which also contained prolactin.
Meinders AE; Willekens FL; Barends CA; Seevinck J; Nieuwenhuijzen Kruseman AC
Neth J Med; 1981; 24(4):136-44. PubMed ID: 7279084
[No Abstract] [Full Text] [Related]
38. Prolactin (PRL)-releasing peptide stimulates PRL secretion from human fetal pituitary cultures and growth hormone release from cultured pituitary adenomas.
Rubinek T; Hadani M; Barkai G; Melmed S; Shimon I
J Clin Endocrinol Metab; 2001 Jun; 86(6):2826-30. PubMed ID: 11397894
[TBL] [Abstract][Full Text] [Related]
39. Calcified pituitary adenoma associated with severe hyperprolactinemia. Case report.
Carapella CM; Pompei P; Mastrostefano R; Occhipinti E; Rocco A; Falaschi P
J Neurosurg; 1983 Nov; 59(5):871-4. PubMed ID: 6619941
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathology, clonality, and hormone production profile of prolactinoma].
Ma WB; Ikeda H; Yoshimoto T
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1382-7. PubMed ID: 16029648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
